Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$2.24 – $3.36
22% from low
Exchange
OTC Link
ADRC
Borrow rate
5.15%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $23.49B | $25.67B | $25.39B | $26.89B | $28.21B | $22.64B | $25.52B | $25.10B |
| Cost of revenue | $6.88B | $7.53B | $7.73B | $8.54B | $8.96B | $16.41B | $7.71B | $7.92B |
| Gross profit | $16.61B | $18.15B | $17.66B | $18.35B | $5.87B | $6.48B | $17.81B | $17.19B |
| Gross margin | 70.7% | 70.7% | 69.6% | 68.2% | 20.8% | 28.6% | 69.8% | 68.5% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $3.85B | $3.94B | $2.18B | $3.01B | $2.76B | $2.44B | $2.90B | −$508.0M |
| EBITDA | $5.58B | $6.28B | $4.16B | $4.42B | $3.30B | $3.37B | $4.42B | $1.04B |
| Net income | $1.57B | $2.57B | $38.0M | $1.75B | $1.53B | $264.0M | $4.83B | $3.86B |
| Net margin | 6.7% | 10.0% | 0.1% | 6.5% | 5.4% | 1.2% | 18.9% | 15.4% |
| EPS (diluted) | 4.32 | 7.04 | 0.10 | 4.56 | 4.20 | 0.72 | 5.48 | 10.52 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $25.8B | $0.00 | $0.00–$0.00 | 0 |
| 2027 | $27.5B | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
LIFE HLTHCRE GRP USP/ADR
No one on the platform currently holds LTGHY.
No tracked institution reports a position in LTGHY as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-06-18 | $0.0559 | 2026-07-13 |
| 2025-12-19 | $0.0836 | 2026-01-06 |
| 2025-09-19 | $0.5421 | 2025-10-07 |
| 2025-06-13 | $0.0470 | 2025-07-02 |
| 2025-01-10 | $0.1458 | 2025-01-28 |
| 2024-12-13 | $0.0682 | 2025-01-02 |
| 2024-06-14 | $0.0420 | 2024-07-03 |
| 2024-04-24 | $1.2908 | 2024-04-23 |
| 2023-12-13 | $0.0584 | 2024-01-02 |
No one on the platform has traded LTGHY yet.
| +0.00% |
| $844M |
| — |
| PHCIPanamera Holdings Corporation | $2.50 | +0.00% | $185M | — |
| RAFLFRaffles Medical Group Ltd | $0.75 | +0.00% | $1.4B | — |
Source: Financial Modeling Prep · peers by sector/industry
| Execution date | Ratio |
|---|
| 2018-06-22 | 1.0141843-for-1 |
| 2018-01-04 | 1.0182456-for-1 |
| 2017-07-05 | 1.0132772-for-1 |
| 2016-12-14 | 1.0296728-for-1 |
| 2016-06-15 | 1.0197479-for-1 |
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.2× earnings vs its 1.2× historical median P/E.
Fair value ≈ $15.06 · price $2.49 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.